Evidence map›Paper›PMID 39315321›Full record

ArticleBio-protocol2024

FixNCut: A Practical Guide to Sample Preservation by Reversible Fixation for Single Cell Assays.

Shuoshuo Wang, Laura Jiménez-Gracia, Antonella Arruda De Amaral, Ioannis S Vlachos, Jasmine Plummer, Holger Heyn, Luciano G Martelotto

Abstract read
In one paragraph

Article in Bio-protocol, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shuoshuo WangSpatial Technologies, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Laura Jiménez-GraciaCentro Nacional de Análisis Genómico (CNAG), Barcelona, Spain.
Antonella Arruda De AmaralSpatial Technologies, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Ioannis S VlachosSpatial Technologies, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Jasmine PlummerCenter for Spatial Omics, St Jude Children's Research Hospital, Memphis, TN, USA.
Holger HeynCentro Nacional de Análisis Genómico (CNAG), Barcelona, Spain.
Luciano G MartelottoAdelaide Centre for Epigenetics (ACE), University of Adelaide, Adelaide, South Australia, Australia.

Funding

Project 2 - BWHP01AI179405 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI George C Tsokos · 2024 to 2026
$8.9M
Organ Specific ProjectU54HL165440 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI HONG, YOUNG-KWON, SINGHAL, DHRUV · 2022 to 2025
$5.8M
NHLBI NIH HHS U54 HL165440NIAID NIH HHS P01 AI179405
6 · The paper itself

Abstract

The quality of standard single-cell experiments often depends on the immediate processing of cells or tissues post-harvest to preserve fragile and vulnerable cell populations, unless the samples are adequately fixed and stored. Despite the recent rise in popularity of probe-based and aldehyde-fixed RNA assays, these methods face limitations in species and target availability and are not suitable for immunoprofiling or assessing chromatin accessibility. Recently, a reversible fixation strategy known as FixNCut has been successfully deployed to separate sampling from downstream applications in a reproducible and robust manner, avoiding stress or necrosis-related artifacts. In this article, we present an optimized and robust practical guide to the FixNCut protocol to aid the end-to-end adaptation of this versatile method. This protocol not only decouples tissue or cell harvesting from single-cell assays but also enables a flexible and decentralized workflow that unlocks the potential for single-cell analysis as well as unconventional study designs that were previously considered unfeasible. Key features • Reversible fixation: Preserves cellular and molecular structures with the option to later reverse the fixation for downstream applications, maintaining cell integrity • Compatibility with single-cell assays: Supports single-cell genomic assays such as scRNA-seq and ATAC-seq, essential for high-resolution analysis of cell function and gene expression • Flexibility in sample handling: Allows immediate fixation post-collection, decoupling sample processing from analysis, beneficial in settings where immediate processing is impractical • Preservation of RNA and DNA integrity: Effectively preserves RNA and DNA, reducing degradation to ensure accurate transcriptomic and genomic profiling • Suitability for various biological samples: Applicable to a wide range of biological samples, including tissues and cell suspensions, whether freshly isolated or post-dissociated • Enables multi-center studies: Facilitates collaborative research across multiple centers by allowing sample fixation at the point of collection, enhancing research scale and diversity • Avoidance of artifacts: Minimizes stress or necrosis-related artifacts, preserving the natural cellular physiology for accurate genomic and transcriptomic analysis.

Indexed as

DSPFixationLomant's reagentSample preservationSingle cellSingle-cell sequencingTissue

Identifiers

PMID39315321
PMCPMC11417608

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.